lomustine has been researched along with Colorectal Neoplasms in 6 studies
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
Excerpt | Relevance | Reference |
---|---|---|
"A prospective controlled randomized trial testing adjuvant postoperative combination chemotherapy (5-fluorouracil, lomustine (CCNU) and vincristine) versus no adjuvant therapy in patients operated on for Dukes' C colorectal cancer is reported." | 9.06 | Adjuvant chemotherapy with 5-fluorouracil, vincristine and CCNU for patients with Dukes' C colorectal cancer. The Swedish Gastrointestinal Tumour Adjuvant Therapy Group. ( Asklöf, G; Bergman, L; Domellöf, L; Hafström, L; Hansson, K; Kugelberg, C; Nilsson, T; Norryd, C; Rudenstam, CM; Wählby, L, 1990) |
"Forty-one patients with metastatic colorectal cancer were treated every four weeks with methotrexate 25 mg/m2 i." | 7.68 | Salvage chemotherapy in colorectal cancer patients with good performance status and young age after failure of 5-fluorouracil/leucovorin combination. ( Cascinu, S; Catalano, G; Fedeli, A; Luzi Fedeli, S, 1992) |
"A prospective controlled randomized trial testing adjuvant postoperative combination chemotherapy (5-fluorouracil, lomustine (CCNU) and vincristine) versus no adjuvant therapy in patients operated on for Dukes' C colorectal cancer is reported." | 5.06 | Adjuvant chemotherapy with 5-fluorouracil, vincristine and CCNU for patients with Dukes' C colorectal cancer. The Swedish Gastrointestinal Tumour Adjuvant Therapy Group. ( Asklöf, G; Bergman, L; Domellöf, L; Hafström, L; Hansson, K; Kugelberg, C; Nilsson, T; Norryd, C; Rudenstam, CM; Wählby, L, 1990) |
"Forty-one patients with metastatic colorectal cancer were treated every four weeks with methotrexate 25 mg/m2 i." | 3.68 | Salvage chemotherapy in colorectal cancer patients with good performance status and young age after failure of 5-fluorouracil/leucovorin combination. ( Cascinu, S; Catalano, G; Fedeli, A; Luzi Fedeli, S, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Krugman, J | 1 |
Patel, K | 1 |
Cantor, A | 1 |
Snuderl, M | 1 |
Cooper, B | 1 |
Zan, E | 1 |
Radmanesh, A | 1 |
Hidalgo, ET | 1 |
Nicolaides, T | 1 |
Cascinu, S | 1 |
Fedeli, A | 1 |
Luzi Fedeli, S | 1 |
Catalano, G | 1 |
Ismail Ali, A | 1 |
Simadibrata, R | 1 |
Aziz Rani, A | 1 |
Chudahman, M | 1 |
Dharmika, D | 1 |
Glimelius, B | 1 |
Påhlman, L | 1 |
Hafström, L | 1 |
Domellöf, L | 1 |
Rudenstam, CM | 1 |
Norryd, C | 1 |
Bergman, L | 1 |
Nilsson, T | 1 |
Hansson, K | 1 |
Wählby, L | 1 |
Asklöf, G | 1 |
Kugelberg, C | 1 |
Abdi, EA | 1 |
Hanson, J | 1 |
Harbora, DE | 1 |
Young, DG | 1 |
McPherson, TA | 1 |
1 review available for lomustine and Colorectal Neoplasms
Article | Year |
---|---|
The value of adjuvant therapy after radical surgery for colorectal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colore | 1992 |
3 trials available for lomustine and Colorectal Neoplasms
Article | Year |
---|---|
The value of adjuvant therapy after radical surgery for colorectal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colore | 1992 |
Adjuvant chemotherapy with 5-fluorouracil, vincristine and CCNU for patients with Dukes' C colorectal cancer. The Swedish Gastrointestinal Tumour Adjuvant Therapy Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Fem | 1990 |
Adjuvant chemoimmuno- and immunotherapy in Dukes' stage B2 and C colorectal carcinoma: a 7-year follow-up analysis.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Clinical T | 1989 |
3 other studies available for lomustine and Colorectal Neoplasms
Article | Year |
---|---|
Pediatric glioblastoma in the setting of constitutional mismatch-repair deficiency treated with upfront lomustine and nivolumab.
Topics: Brain Neoplasms; Child; Colorectal Neoplasms; Glioblastoma; Humans; Lomustine; Nivolumab | 2024 |
Salvage chemotherapy in colorectal cancer patients with good performance status and young age after failure of 5-fluorouracil/leucovorin combination.
Topics: Adenocarcinoma; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neopl | 1992 |
Chemotherapy for colorectal carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chemotherapy, Adjuvant; Colorectal Neopl | 1992 |